Amina Abu‐Omar

491 total citations · 1 hit paper
7 papers, 277 citations indexed

About

Amina Abu‐Omar is a scholar working on Infectious Diseases, Epidemiology and Animal Science and Zoology. According to data from OpenAlex, Amina Abu‐Omar has authored 7 papers receiving a total of 277 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Infectious Diseases, 3 papers in Epidemiology and 2 papers in Animal Science and Zoology. Recurrent topics in Amina Abu‐Omar's work include SARS-CoV-2 and COVID-19 Research (5 papers), COVID-19 Clinical Research Studies (4 papers) and Animal Virus Infections Studies (2 papers). Amina Abu‐Omar is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (5 papers), COVID-19 Clinical Research Studies (4 papers) and Animal Virus Infections Studies (2 papers). Amina Abu‐Omar collaborates with scholars based in Germany and United States. Amina Abu‐Omar's co-authors include Verena Klemis, Franziska Hielscher, Rebecca Urschel, Candida Guckelmus, Tina Schmidt, Martina Sester, Stefanie Marx, Urban Sester, Laura Ziegler and Barbara C. Gärtner and has published in prestigious journals such as Nature Medicine, Nature Communications and American Journal of Transplantation.

In The Last Decade

Amina Abu‐Omar

6 papers receiving 272 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Immunogenicity and reactogenicity of heterologous ChAdOx1 nCoV-19/mRNA vaccination

2021 216 citations Tina Schmidt, Verena Klemis et al. Nature Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Amina Abu‐Omar Germany	5	252	73	63	36	34	7	277
Candida Guckelmus Germany	5	252 1.0×	73 1.0×	63 1.0×	36 1.0×	34 1.0×	5	276
Rebecca Urschel Germany	5	253 1.0×	73 1.0×	63 1.0×	36 1.0×	34 1.0×	6	277
Franziska Hielscher Germany	5	253 1.0×	73 1.0×	64 1.0×	37 1.0×	40 1.2×	8	301
Laura Ziegler Germany	4	250 1.0×	73 1.0×	61 1.0×	42 1.2×	39 1.1×	4	280
Suvichada Assawakosri Thailand	9	286 1.1×	91 1.2×	59 0.9×	45 1.3×	26 0.8×	22	299
Thaksaporn Thatsanatorn Thailand	9	253 1.0×	89 1.2×	52 0.8×	39 1.1×	25 0.7×	13	264
Christopher Menne Germany	3	296 1.2×	65 0.9×	52 0.8×	40 1.1×	29 0.9×	4	340
Wiebke Moskorz Germany	4	297 1.2×	65 0.9×	51 0.8×	48 1.3×	34 1.0×	6	357
Biliana Nestorova United States	3	231 0.9×	61 0.8×	46 0.7×	45 1.3×	62 1.8×	3	272
Leo L. H. Luk Hong Kong	5	257 1.0×	53 0.7×	46 0.7×	24 0.7×	41 1.2×	8	273

Countries citing papers authored by Amina Abu‐Omar

Since Specialization

Citations

This map shows the geographic impact of Amina Abu‐Omar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amina Abu‐Omar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amina Abu‐Omar more than expected).

Fields of papers citing papers by Amina Abu‐Omar

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amina Abu‐Omar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amina Abu‐Omar. The network helps show where Amina Abu‐Omar may publish in the future.

Co-authorship network of co-authors of Amina Abu‐Omar

This figure shows the co-authorship network connecting the top 25 collaborators of Amina Abu‐Omar. A scholar is included among the top collaborators of Amina Abu‐Omar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amina Abu‐Omar. Amina Abu‐Omar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

Abu‐Omar, Amina, Danilo Fliser, Tina Schmidt, et al.. (2025). Cellular and humoral immunogenicity of respiratory syncytial virus vaccination in solid organ transplant recipients. American Journal of Transplantation. 26(3). 499–511.

2.

Abu‐Omar, Amina, et al.. (2025). CMV management of patients with leukopenia after CMV high-risk kidney transplantation. Transplant Immunology. 89. 102188–102188. 1 indexed citations

3.

Mihm, Janine, Rebecca Urschel, Verena Klemis, et al.. (2024). Potent induction of humoral and cellular immunity after bivalent BA.4/5 mRNA vaccination in dialysis patients. npj Vaccines. 9(1). 25–25. 4 indexed citations

4.

Urschel, Rebecca, Verena Klemis, Stefanie Marx, et al.. (2024). SARS-CoV-2-specific cellular and humoral immunity after bivalent BA.4/5 COVID-19-vaccination in previously infected and non-infected individuals. Nature Communications. 15(1). 3077–3077. 7 indexed citations

5.

Hielscher, Franziska, Tina Schmidt, Verena Klemis, et al.. (2022). NVX-CoV2373-induced cellular and humoral immunity towards parental SARS-CoV-2 and VOCs compared to BNT162b2 and mRNA-1273-regimens. Journal of Clinical Virology. 157. 105321–105321. 19 indexed citations

6.

Klemis, Verena, Tina Schmidt, David Schub, et al.. (2022). Comparative immunogenicity and reactogenicity of heterologous ChAdOx1-nCoV-19-priming and BNT162b2 or mRNA-1273-boosting with homologous COVID-19 vaccine regimens. Nature Communications. 13(1). 4710–4710. 30 indexed citations

7.

Schmidt, Tina, Verena Klemis, David Schub, et al.. (2021). Immunogenicity and reactogenicity of heterologous ChAdOx1 nCoV-19/mRNA vaccination. Nature Medicine. 27(9). 1530–1535. 216 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact